找化学品上960化工网!
960化工网

妥拉磺脲 | 1156-19-0

妥拉磺脲
Tolazamide
1156-19-0
C14H21N3O3S
311.3998
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:妥拉磺脲结构式
329751338
妥拉磺脲价格
简介
妥拉磺脲为中效磺酰脲衍生物,临床适用于食物疗法不能有效控制血糖的成人2型糖尿病。
名称和标识符
MDL MFCD00083504
InChIKey OUDSBRTVNLOZBN-UHFFFAOYSA-N
Inchi 1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)
SMILES S(C1C([H])=C([H])C(C([H])([H])[H])=C([H])C=1[H])(N([H])C(N([H])N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])=O)(=O)=O
别名信息
- 中文别名 -
  • 妥拉磺脲
  • 甲磺氮草脲
  • 1-羟基-1H-1,2,3-三唑-4-羧酸乙酯
  • 2-(2-(苄氧基羰基氨基)(1,3-d6-丙烷)-2-基)-5-羰基-1-(甲基-d3)-6-氧代-1,6-二氢嘧啶-4-甲酸甲酯
  • 甲磺吖庚脲
  • 甲磺氮卓脲
  • 妥拉磺脲 USP标准品
  • 妥拉磺脲标准品(JP)
  • 对甲苯磺酰六氢氮脲
  • 甲磺氮脲
- 英文别名 -
  • Tolazamide
  • Tolazolamide
  • Benzenesulfonamide,N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-
  • U-17835
  • 1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea
  • 1-(Hexahydro-1H-azepin-1-yl)-3-(p-toluenesulfonyl)urea
  • Tolinase
  • Norglycin
  • Tolanase
  • Diabewas
  • Tolazamidum
  • Tolazamida
  • 1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea
  • N-(p-Toluenesulfonyl)-N'-hexamethyleniminourea
  • 4-(p-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide
  • 1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea
  • Tolazamidum [INN-Latin]
  • Tolazamida [INN-Spanish]
  • U 17835
  • Urea, 1-(hexahydroazepin-1-yl)-3-p-tolylsulfonyl-
  • Urea, 1-(hexahydro-1H-azepin-
  • CHEMBL817
  • BSPBio_001505
  • DivK1c_000212
  • Urea, 1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)-
  • 1-(((((4-Methylphenyl)sulfonyl)amino)carbonyl)amino)azepane
  • AB00052247
  • KBio1_000212
  • Tolazamida (INN-Spanish)
  • N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methylbenzenesulfonamide
  • Tolazamide [USAN:USP:INN:BAN:JAN]
  • TOLAZAMIDE [WHO-DD]
  • OUDSBRTVNLOZBN-UHFFFAOYSA-N
  • 1-[(Azepan-1-ylamino)carbonyl]-4-methylbenzenesulfonamide
  • Bio2_000705
  • KS-1438
  • NCI-C03327
  • TOLAZAMIDE [JAN]
  • NCGC00254501-01
  • TOLAZAMIDE [VANDF]
  • Prestwick2_000554
  • tolazamide
  • CBiol_001918
  • Lopac-T-2408
  • Lopac0_001195
  • A10BB05
  • NSC758149
  • A921617
  • N-(azepan-1-ylcarbamoyl)-4-methylbenzenesulfonamide
  • HMS1569P09
  • TOLBUTAMIDE IMPURITY C [EP IMPURITY]
  • TOLAZAMIDE (USP MONOGRAPH)
  • T 2408
  • BPBio1_000691
  • NCGC00016009-13
  • NCGC00261880-01
  • SR-01000003105-2
  • NCGC00016009-19
  • BRD-K32164935-001-28-2
  • KBio3_000450
  • TOLAZAMIDE [USAN]
  • Opera_ID_1740
  • NSC70762
  • LP01195
  • TOLAZAMIDE [USP-RS]
  • NINDS_000212
  • NCGC00016009-14
  • Tolazamide (USAN:USP:INN:BAN:JAN)
  • DB00839
  • Pharmakon1600-01501201
  • NCGC00016009-06
  • 1-(azepan-1-yl)-3-[(4-methylbenzene)sulfonyl]urea
  • Prestwick_865
  • SDCCGSBI-0051162.P004
  • Benzenesulfonamide, {N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-}
  • 5-20-04-00062 (Beilstein Handbook Reference)
  • MLS000028534
  • NCGC00016009-15
  • HMS1921P19
  • KBio3_002525
  • Tolinase (TN)
  • NC00590
  • CHEBI:9613
  • NCGC00023701-06
  • Oprea1_061180
  • NCGC00016009-11
  • HMS2092L09
  • Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methyl-
  • 3-(Azepan-1-yl)-1-(4-methylphenyl)Sulfonyl-Urea
  • NCGC00016009-07
  • BSPBio_000627
  • Tox21_300416
  • Prestwick1_000554
  • C71499
  • Tox21_110281_1
  • HMS1361L07
  • HMS2232L21
  • NCGC00023701-04
  • TOLAZAMIDE [INN]
  • HMS500K14
  • Spectrum2_001449
  • SPBio_001317
  • Tolazamidum (INN-Latin)
  • NS00007143
  • SW196991-3
  • SR-01000003105-5
  • F2173-1137
  • 1-[(([(4-Methylphenyl)sulfonyl]amino)carbonyl)amino]azepane #
  • NSC-758149
  • NCGC00023701-08
  • NCGC00016009-01
  • UNII-9LT1BRO48Q
  • NCGC00259058-01
  • Q7814101
  • BRN 1323565
  • HY-B0920
  • MFCD00083504
  • AB00052247-15
  • BRD-K32164935-001-06-8
  • Tox21_110281
  • NSC-70762
  • TOLAZAMIDE (USP-RS)
  • BCBcMAP01_000061
  • N-[[(Hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methylbenzenesulfonamide
  • KBio2_002793
  • HMS3259O18
  • 1-(azepan-1-yl)-3-(4-methylbenzenesulfonyl)urea
  • HMS1989L07
  • KBioSS_000225
  • Bio1_000204
  • 1-(azepan-1-yl)-3-(p-tolylsulfonyl)urea
  • HMS3713P09
  • SMR000058290
  • D00379
  • KBioGR_000225
  • NCGC00016009-09
  • NSC 70762
  • HMS3369L04
  • Benzenesulfonamide, N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-
  • NCGC00023701-07
  • NCGC00023701-10
  • KBioGR_000939
  • NCIOpen2_008361
  • KBio2_005361
  • Tox21_501195
  • TOLBUTAMIDE IMPURITY C (EP IMPURITY)
  • KBio2_000225
  • Tolazamide, United States Pharmacopeia (USP) Reference Standard
  • Benzenesulfonamide, N-[[(hexahydro-1-azepinyl)amino]carbonyl]-4-methyl-
  • Ronase
  • Tox21_201507
  • TOLAZAMIDE [HSDB]
  • SBI-0051162.P003
  • NCGC00016009-08
  • Bio1_000693
  • 1-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]azepane
  • HSDB 3192
  • NCGC00016009-12
  • KBio2_006885
  • TOLAZAMIDE [MI]
  • AB00052247_17
  • W-109110
  • EU-0101195
  • HMS3263P11
  • IDI1_033975
  • Tolazamide (JAN/USP/INN)
  • FT-0675268
  • Bio2_000225
  • CAS-1156-19-0
  • BENZENESULFONAMIDE, N,((HEXAHYDRO-1H-AZEPIN-1-YL)AMINO)CARBONYL)-4-METHYL-
  • Spectrum_001269
  • SPECTRUM1501201
  • Spectrum4_000240
  • BCP23550
  • NCGC00016009-04
  • CCRIS 591
  • NCGC00023701-03
  • KBio3_000449
  • NCGC00016009-05
  • Prestwick0_000554
  • KBio2_001749
  • NCGC00016009-02
  • NCGC00016009-03
  • NCGC00023701-09
  • AKOS015913823
  • SR-01000003105-8
  • MLS001076161
  • NCGC00016009-24
  • N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide
  • EINECS 214-588-3
  • TOLAZAMIDE (MART.)
  • TOLAZAMIDE [ORANGE BOOK]
  • SCHEMBL34417
  • NCGC00016009-16
  • NCGC00016009-10
  • SPBio_002548
  • Prestwick3_000554
  • IDI1_000212
  • WLN: T7NTJ AMVMSWR D1
  • Z1575267190
  • DTXCID401358
  • TOLAZAMIDE [MART.]
  • SR-01000003105-4
  • HMS2089L10
  • BRD-K32164935-001-17-5
  • AB00052247_16
  • 1-(4-Methylphenylsulfonyl)-3-(hexahydro-1H-azepin-1-yl)urea
  • DTXSID3021358
  • HMS3402L07
  • KBioSS_001749
  • GTPL6847
  • Spectrum5_001204
  • HMS2096P09
  • TOLAZAMIDE [USP MONOGRAPH]
  • HMS1791L07
  • NCI-CO3327
  • 1156-19-0
  • KBio2_004317
  • Tolazamid
  • CCG-39178
  • N-[(azepan-1-ylamino)carbonyl]-4-methylbenzenesulfonamide
  • 3-azepan-1-yl-1-(4-methylphenyl)sulfonyl-urea
  • NCGC00016009-17
  • 9LT1BRO48Q
  • N-(((Hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methylbenzenesulfonamide
  • SR-01000003105
  • Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methyl-
  • AI3-50826
  • Bio1_001182
  • NCGC00023701-05
  • BSPBio_003025
  • Spectrum3_001473
  • inverted exclamation markY96%(T)
物化性质
实验特性
LogP 3.57440
PSA 86.89000
折射率 1.6740 (estimate)
沸点 300°C (rough estimate)
熔点 162-164°C
蒸气压 0.0±1.3 mmHg at 25°C
闪点 °C
颜色与性状 未确定
溶解性 未确定
酸度系数(pKa) 3.6(at 25℃)
密度 1.2228 (rough estimate)
计算特性
精确分子量 311.13000
氢键供体数量 2
氢键受体数量 4
可旋转化学键数量 3
同位素质量 311.130362
重原子数量 21
复杂度 431
同位素原子数量 0
确定原子立构中心数量 0
不确定原子立构中心数量 0
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 1.5
互变异构体数量 3
表面电荷 0
拓扑分子极性表面积 86.9
国际标准相关数据
EINECS 591
海关数据
海关编码 2935009090
海关数据

中国海关编码:

2935009090

概述:

2935009090 其他磺(酰)胺. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:35.0%

申报要素:

品名, 成分含量, 用途

Summary:

2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

相关文献
专业数据库参考
PubChemId 329751338
参考资料
Reaxys RN
化合物详情(旧版)

SMILES

C1CCN(CCC1)NC(=O)NS(=O)(=O)C2=CC=C(C)C=C2

物理化学性质

产品用途

应用领域







上下游产品信息




化学品安全说明书(MSDS)



储运特性





960化工网为您提供妥拉磺脲专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:1156-19-0,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:1156-19-0
平台客服 平台客服

平台在线客服